Intellectual Property Rights Related to Medicinal Plants

Medicinal plants are regarded as a rich source of components that have been used in medicine discovery and synthesis for millennia. However, the modern pharmaceutical industry and biotechnology firms have pushed to patent and commercialize chemicals derived from these plants, posing serious ethical considerations. This chapter discusses intellectual property rights (IPR) in relation to medicinal plants, including IPR relevance to medicinal plants, international agreements, international treaties and conventions, and ethical contemplations. Although improper stealing of indigenous nations’ traditional knowledge and genetic resources is a major ethical concern. IPR encompasses a variety of legal protections and strategies that protect these concerns from various sorts of intellectual creations and inventions. Among these are patents, plant variety protection, trademarks, geographical indications, trade secrets, and confidential information, each of which serves a different function and protects different components of intellectual property. However, legal frameworks such as the Nagoya Protocol, the Convention on Biological Diversity (CBD), the Intergovernmental Committee on Intellectual Property and Genetic Resources (IGC), and others can be used to negotiate access to genetic resources and share the advantages that result from their use. As a result, the ethical issues surrounding IPR and medicinal plants underscore the need for comprehensive and collaborative strategies that balance different viewpoints and support for both innovation and cultural preservation.